BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA

World News: . []

NEW YORK and IRVINE Calif Jan 11 2019 GLOBE NEWSWIRE -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases announced today a nnounce...

More news and information about BrainStorm Cell Therapeutics Inc.

Published By:

Globe Newswire: 05:05 GMT Friday 11th January 2019

Published: .

Search for other references to "brainstorm" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us